PPD Inc (PPD) Stock Price, Quote, News and Overview
NASDAQ:PPD - Nasdaq - Common Stock
PPD Quote, Performance and Key Statistics
47.28
-0.03 (-0.06%)
The current stock price of PPD is 47.28 null. In the past month the price increased by 0.06%. In the past year, price increased by 37.36%.
PPD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B |
Related stock screener links
About PPD
Company Profile
PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The company is headquartered in Wilmington, North Carolina and currently employs 26,000 full-time employees. The company went IPO on 2020-02-06. The firm provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The firm operates through two segments: Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides a range of services to its customers including early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment provides services to its customers including bioanalytical, vaccine sciences, good manufacturing practice (GMP), central lab and biomarker testing.
Company Info
PPD Inc
929 North Front Street
Wilmington NORTH CAROLINA 28401 US
CEO: David Simmons
Employees: 26000
Company Website: https://www.ppd.com/
Phone: 19102510081.0
PPD Inc / PPD FAQ
What is the stock price of PPD Inc today?
The current stock price of PPD is 47.28 null. The price decreased by -0.06% in the last trading session.
What is the ticker symbol for PPD Inc stock?
The exchange symbol of PPD Inc is PPD and it is listed on the Nasdaq exchange.
On which exchange is PPD stock listed?
PPD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PPD Inc stock?
17 analysts have analysed PPD and the average price target is 48.25 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 47.28. Check the PPD Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PPD Inc worth?
PPD Inc (PPD) has a market capitalization of 17.00B null. This makes PPD a Large Cap stock.
How many employees does PPD Inc have?
PPD Inc (PPD) currently has 26000 employees.
What are the support and resistance levels for PPD Inc (PPD) stock?
PPD Inc (PPD) has a support level at 47.26 and a resistance level at 47.36. Check the full technical report for a detailed analysis of PPD support and resistance levels.
Is PPD Inc (PPD) expected to grow?
The Revenue of PPD Inc (PPD) is expected to grow by 31.13% in the next year. Check the estimates tab for more information on the PPD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PPD Inc (PPD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PPD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PPD, evaluating the profitability, health, valuation and growth aspects
- PPD Inc (PPD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PPD Inc (PPD) Sales and EPS estimates to see what analysts future expectations are.
- PPD Inc (PPD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PPD Inc (PPD) Insider and Institutional Ownership to learn about the owners and their transactions.
- PPD Inc (PPD) Stock Chart to make your own analysis
- PPD Inc (PPD) Latest news and press-releases to stay up to date.
Does PPD Inc (PPD) stock pay dividends?
PPD does not pay a dividend.
When does PPD Inc (PPD) report earnings?
PPD Inc (PPD) will report earnings on 2022-03-01, after the market close.
What is the Price/Earnings (PE) ratio of PPD Inc (PPD)?
The PE ratio for PPD Inc (PPD) is 30.31. This is based on the reported non-GAAP earnings per share of 1.56 and the current share price of 47.28 null. Check the full fundamental report for a full analysis of the valuation metrics for PPD.
PPD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PPD. When comparing the yearly performance of all stocks, PPD is one of the better performing stocks in the market, outperforming 82.3% of all stocks.
PPD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PPD. Both the profitability and the financial health of PPD get a neutral evaluation. Nothing too spectacular is happening here.
PPD Financial Highlights
Over the last trailing twelve months PPD reported a non-GAAP Earnings per Share(EPS) of 1.56. The EPS increased by 39.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.19% | ||
| ROA | 5.18% | ||
| ROE | N/A | ||
| Debt/Equity | -9.91 |
PPD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 53% to PPD. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of 37.26% and a revenue growth 31.13% for PPD